NCT02300740View on ClinicalTrials.gov

Pharmacokinetic Analysis of Nicotinamide Riboside

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

February 28, 2015

Conditions
Healthy Participants
Interventions
DIETARY_SUPPLEMENT

Nicotinamide riboside

NIAGEN, ChromaDex

Trial Locations (1)

8000

Medical Research Laboratories, Aarhus University Hospital, Aarhus

All Listed Sponsors
collaborator

University of Copenhagen

OTHER

lead

Aarhus University Hospital

OTHER

NCT02300740 - Pharmacokinetic Analysis of Nicotinamide Riboside | Biotech Hunter | Biotech Hunter